%D9%84%D9%85%D9%81%D9%88%D9%85%D8%A7_%D8%A8%D9%8A%D8%B1%D9%83%D8%AALimfoma_de_BurkittCategory:Burkitt%27s_lymphomaBurkitt%C5%AFv_lymfomBurkitt-Lymphom%CE%9B%CE%AD%CE%BC%CF%86%CF%89%CE%BC%CE%B1_%CF%84%CE%BF%CF%85_%CE%9C%CF%80%CE%AD%CF%81%CE%BA%CE%B5%CF%84Burkitt%27s_lymphomaLinfoma_de_Burkitt%D9%84%D9%86%D9%81%D9%88%D9%85_%D8%A8%D9%88%D8%B1%DA%A9%DB%8C%D8%AABurkittin_lymfoomaLymphome_de_Burkitt%D7%9C%D7%99%D7%9E%D7%A4%D7%95%D7%9E%D7%AA_%D7%91%D7%99%D7%A8%D7%A7%D7%99%D7%98Burkitt-limf%C3%B3maLimfoma_BurkittLinfoma_di_Burkitt%E3%83%90%E3%83%BC%E3%82%AD%E3%83%83%E3%83%88%E3%83%AA%E3%83%B3%E3%83%91%E8%85%AB%EB%B2%84%ED%82%B7%EB%A6%BC%ED%94%84%EC%A2%85Burkitt_limfoma%E0%B4%AC%E0%B5%BC%E0%B4%95%E0%B5%8D%E0%B4%95%E0%B4%BF%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B5%8D%E0%B4%B8%E0%B5%8D_%E0%B4%B2%E0%B4%BF%E0%B4%82%E0%B4%AB%E0%B5%8B%E0%B4%AEBurkittlymfoomBurkitt-lymfekreftCh%C5%82oniak_BurkittaLinfoma_de_Burkitt%D0%9B%D0%B8%D0%BC%D1%84%D0%BE%D0%BC%D0%B0_%D0%91%D1%91%D1%80%D0%BA%D0%B8%D1%82%D1%82%D0%B0%D0%9B%D1%96%D0%BC%D1%84%D0%BE%D0%BC%D0%B0_%D0%91%D0%B5%D1%80%D0%BA%D1%96%D1%82%D1%82%D0%B0Q1016605
about
sameAs
Namrata Singh GujralLenalidomide and Blinatumomab in Treating Patients With Relapsed Non-Hodgkin LymphomaBlinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaPhase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell LymphomaIbrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaCD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic LeukemiaBlinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia With High Marrow LymphoblastsA Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma SubjectsBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerAnti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic LeukemiaIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesPlerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesEverolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaBiomarkers in Samples From Patients With B-Cell Acute Lymphoblastic LeukemiaPilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic LeukemiaRituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaEvaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerIodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's LymphomaDecitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomasMDX-010 in Treating Patients With Recurrent or Refractory LymphomaTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerLow-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple MyelomaFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerThe EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLRasburicase and Allopurinol in Treating Patients With Hematologic MalignanciesAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaStudying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic LeukemiaDonor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid MalignanciesCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesSafety and Tolerability of HSC835 in Patients With Hematological MalignanciesLenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell TransplanImexon for Relapsed Follicular and Aggressive LymphomasVeliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid TumorsPalifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
P1050
P2175
Burkitt's tumor or lymphoma involving intrathoracic lymph nodesBurkitt's tumor or lymphoma involving lymph nodes of head, face, and neckBurkitt's tumor or lymphoma involving intrapelvic lymph nodesBurkitt's tumor or lymphoma involving lymph nodes of axilla and upper limbBurkitt's tumor or lymphoma involving lymph nodes of multiple sitesBurkitt's tumor or lymphoma involving spleenBurkitt's tumor or lymphoma involving intra-abdominal lymph nodesEpstein-Barr virus-related Burkitt lymphomaadult Burkitt lymphomacolon Burkitt lymphomasmall intestinal Burkitt lymphoma
P279
The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based surveyt(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemiaA global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cellsTherapeutic interventions for Burkitt lymphoma in childrenTherapeutic interventions for Burkitt's lymphoma in childrenTherapeutic interventions for endemic Burkitt's lymphoma in childrenDifferentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphomaCloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissuesMolecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmonOncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line AkataChromosome 8 breakpoint far 3' of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus.Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma linesIdentification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphomaEpstein-Barr virus and Burkitt lymphomaIntegration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expressionBurkitt's lymphoma: new insights into molecular pathogenesisMORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAT cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma linesAre plant factors a missing link in the evolution of endemic Burkitt's lymphoma?Excessive centrosome abnormalities without ongoing numerical chromosome instability in a Burkitt's lymphomaThe Link between Plasmodium falciparum Malaria and Endemic Burkitt's Lymphoma-New Insight into a 50-Year-Old EnigmaRapid and label-free separation of Burkitt's lymphoma cells from red blood cells by optically-induced electrokineticsIsolation of a Reovirus from a Case of Burkitt's LymphomaFurther isolations of reovirus type 3 from cases of Burkitt's lymphomaBurkitt's lymphoma in Africa, a review of the epidemiology and etiologyComplete remission of gastric Burkitt's lymphoma after eradication of Helicobacter pyloriCloning and sequence analysis of an Ig lambda light chain mRNA expressed in the Burkitt's lymphoma cell line EB4Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas I: mantle cell lymphoma, follicular lymphoma, and Burkitt's lymphomaEBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphomaNuclear localization of the Epstein-Barr virus/C3d receptor (CR2) in the human Burkitt B lymphoma cell, RajiPBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cellsHigh expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphomaIdiopathic CD4+ T-lymphocytopenia terminating in Burkitt's lymphomaDNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoproteinDifferentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring systemA B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomasMechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphomaA non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas
P921
description
Krankheit
@de
mature B-cell neoplasm of B-cells found in the germinal center
@en
nádorové onemocnění
@cs
злоякісна пухлина лімфоїдної системи
@uk
name
Burkitt limfoma
@lt
Burkitt lymphoma
@en
Burkitt-Lymphom
@de
Burkitt-en linfoma
@eu
Burkitt-limfóma
@hu
Burkittin lymfooma
@fi
Burkittlymfoom
@nl
Burkitts lymfom
@nn
Burkitův lymfom
@cs
Chłoniak Burkitta
@pl
type
label
Burkitt limfoma
@lt
Burkitt lymphoma
@en
Burkitt-Lymphom
@de
Burkitt-en linfoma
@eu
Burkitt-limfóma
@hu
Burkittin lymfooma
@fi
Burkittlymfoom
@nl
Burkitts lymfom
@nn
Burkitův lymfom
@cs
Chłoniak Burkitta
@pl
altLabel
Burkitt lymfoom
@nl
Burkitt lymphoma/leukaemia
@en
Burkitt
@pt
Burkitt's Lymphoma
@en
Burkitt's lymphoma
@ml
Burkitt's tumor or lymphoma
@en
Burkitt's tumor
@en
Burkitt-lymfom
@nn
C83.7
@de
Limfoma burkitt
@id
prefLabel
Burkitt limfoma
@lt
Burkitt lymphoma
@en
Burkitt-Lymphom
@de
Burkitt-en linfoma
@eu
Burkitt-limfóma
@hu
Burkittin lymfooma
@fi
Burkittlymfoom
@nl
Burkitts lymfom
@nn
Burkitův lymfom
@cs
Chłoniak Burkitta
@pl
P2888
P672
P486
P508
P6366
P646
P672
P1296
P1417
science/Burkitt-lymphoma
P1461
Burkitts-Lymphoma